Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Income from Non-Controlling Interests: 2017-2020

Historic Income from Non-Controlling Interests for Myriad Genetics (MYGN) over the last 4 years, with Dec 2020 value amounting to -$100,000.

  • Myriad Genetics' Income from Non-Controlling Interests changed negligibly% to -$100,000 in Q2 2020 from the same period last year, while for Jun 2020 it was -$400,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -$100,000 for FY2020, which is N/A change from last year.
  • Myriad Genetics' Income from Non-Controlling Interests amounted to -$100,000 in FY2020, which was down 0.00% from -$100,000 recorded in FY2020.
  • Myriad Genetics' Income from Non-Controlling Interests' 5-year high stood at -$100,000 during FY2020, with a 5-year trough of -$200,000 in FY2017.
  • Moreover, its 3-year median value for Income from Non-Controlling Interests was -$150,000 (2018), whereas its average is -$150,000.
  • Data for Myriad Genetics' Income from Non-Controlling Interests shows a peak YoY surged of 50.00% (in 2020) over the last 5 years.
  • Over the past 4 years, Myriad Genetics' Income from Non-Controlling Interests (Yearly) stood at -$200,000 in 2017, then remained steady at -$200,000 in 2018, then remained steady at -$200,000 in 2019, then spiked by 50.00% to -$100,000 in 2020, then reached -$100,000 in 2020.